L-032-1ML Display Image

Lacosamide-13C, D3 solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material

Code: L-032-1ML D2-231

General description

An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing a...


read more

Your Price
£684.22 1ML
£821.06 inc. VAT
REQUEST

General description

An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®.

Legal Information

Snap-N-Spike is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

Vimpat is a registered trademark of Harris FRC Corporation

application(s)clinical testing
concentration1.0 mg/mL in acetonitrile
featureSnap-N-Spike®/Snap-N-Shoot®
formliquid
formatsingle component solution
gradecertified reference material
InChI keyVPPJLAIAVCUEMN-RUXIMPAMSA-N
InChI1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1/i2+1D3
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
SMILES string[2H][13C]([2H])([2H])OC[C@@H](NC(C)=O)C(=O)NCc1ccccc1
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Hazard Class3
Un Number1648
Pack Group2
This product has met the following criteria: